CSASDSSilverman-Andersen and Downes Scores for Neonatal Respiratory Distress
Data Collection
Collected from today forward - ProspectiveDyspnea+10
+ Hyaline Membrane Disease
+ Infant, Newborn, Diseases
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: September 15, 2025
Actual date on which the first participant was enrolled.This study focuses on evaluating two different scoring systems, the Silverman-Andersen score and the Downes score, to assess how well they predict the need for more intensive breathing support in newborns experiencing breathing difficulties shortly after birth. Specifically, it looks at preterm infants born after 28 weeks and full-term infants who show signs of respiratory distress within the first six hours of life. These scoring systems help determine the severity of the condition and whether the babies require additional interventions beyond noninvasive ventilation. The potential benefit of this study is to improve early detection of serious respiratory issues and ensure timely, effective treatment, ultimately reducing the number of newborns who need invasive procedures. In the study, the infants are given noninvasive positive pressure ventilation (NIPPV) using short nasal prongs connected to a mechanical ventilator. Medical staff monitor the infants' breathing rates, oxygen levels, and other vital signs. The performance of the Silverman-Andersen and Downes scores is tested by recording these scores shortly after starting NIPPV and comparing them with actual outcomes, like how long the infants need ventilation and whether they eventually require more intensive support. The study also examines other factors, such as blood gas levels and oxygen requirements, to see how well the scores predict the need for further intervention. The goal is to find out which scoring system provides the most accurate early warning of potential ventilation failure, guiding better treatment decisions for these vulnerable infants.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.220 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 4 locations
Akdeniz University School of Medicine, Department of Neonatology
Antalya, Turkey (Türkiye)Open Akdeniz University School of Medicine, Department of Neonatology in Google MapsAntalya Training and Research Hospital, Department of Neonatology
Antalya, Turkey (Türkiye)Mugla Training and Research Hospital, Department of Neonatology
Muğla, Turkey (Türkiye)Sanliurfa Training and Research Hospital, Department of Neonatology
Sanliurfa, Turkey (Türkiye)